pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3911 |
Genomic Coordinates | chr9: 127690687 - 127690795 |
Description | Homo sapiens miR-3911 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3911 | |||||||||||||||||||||||||||
Sequence | 12| UGUGUGGAUCCUGGAGGAGGCA |33 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ARPP19 | ||||||||||||||||||||
Synonyms | ARPP-16, ARPP-19, ARPP16, ENSAL | ||||||||||||||||||||
Description | cAMP regulated phosphoprotein 19 | ||||||||||||||||||||
Transcript | NM_006628 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ARPP19 | |||||||||||||||||||||
3'UTR of ARPP19 (miRNA target sites are highlighted) |
>ARPP19|NM_006628|3'UTR 1 TTAAGAGGCTGAACTGCATGAATCTGCTAAATCTCATTATTTCTCCTTAATATGTTACTTATCTACTTTTTATTTCCTTT 81 CATTCACTAGTCATTTGAGACTGACAGCTTTGCAGGTAGCAGTAGTGTGTGCTGCTATTGTGGAATATACGTGTGTAGAG 161 TTTTTGATTAGTTTAACAGTGCACTGGTGAAGAGGACATGTTAGAGCAACATAAGTAAACTACTTGAAAATAGTTGTATA 241 TATTACCTAACTTCTAGTGTAGTACTGGTTCTAACAAGTAACAAGCAAGTTTTAAAATTTTAATGTTTTGGCTTTCATTA 321 CTTCATCTTAATTATAGCTTTGTATGTTACTCTTATTTAATATAATCTCTATTGTATTGATTTCTTCTGTATTTACCTTT 401 TGGATTTTGTAAAACAGAAGTTTAAGACCACAAGTTAGAAGAAAGGTCACATATTTCAAACACAACTAGATGGGGCTCTG 481 AAAGATTTGTATCTCTGTGCTTGAACTTGAATGGCCTTAAACCTGTTTCAGCTTTAACAGTAGAATTTTACTTGGGCAAT 561 ATTTGCCCATTCTGGTGTAACTTATGTGACTCTAGTGCTTAACAGCTGCCGTTGAAGCTAATATTCAGTTCTGTAGAGTT 641 AGAATACCTTTTGTTGTTGAAGATGTGAATGAAGTATGCATGTGCATTAACTGTTGAATTCACTTTTGTGCCATTTTTGT 721 AAATACAGTAGTTTTGCACAACCTCTCACAAATGTCTGTATTAATTTCACATACTTAAAAAGTAGATAATGTGCCAACCA 801 GAAGCACAAGAGTTCCTACACAAAACTCTGTAAATCATTATAGCTTTTGTATAATAAGAGTAGTTTACAATCTCGGGCTT 881 ATAGAATACCAAACTGAAATCTTAGTTCAATCTGCCATAGACTTAAGCTTTTCATTTGTTACTAATATCCATGACATTCA 961 GTGGCCTTGTGCAAATACGATATGTTGCTTAGGCATATCTTTTGTCCTATGCAGAACCTTTCATTTTGATTTTTATGAAA 1041 GTTGCAATTCATGTAATTTATATAAACTTTTTAAATGTAGAAACTTTTTACTTCCACACTCAGTTTTGGAGACCCTAGAA 1121 TAAAAGGCTTCAATACTCTGCATTCCATGCCCTCTGCCACCTGCTTTTTTTTCCCCTTTGTTCTTTGACTCAAATGGTAT 1201 TGAGCTGTTTGTTGTATATGGAAGCATAGGTGTCTATATCCTTACTCTTTTATATAACACAATAATGGCGTTTTCCTTCT 1281 AATTTCTCAGTTGTTAACTTCTTTCTCTTTTTTTTTTAGGATAGGGCCTTGCTCTGTCACCTGAGCTCTAGTGCAGTAGT 1361 GCAATCACAGCTCACTGCAACCTTACTCCTAGGCTCAAGTTAACTATTCTTGATCCTTTATTATTACTAATATTCTACAA 1441 TTGTTTAAATAAAAGGAACTTTATAATGAAACGGTTCGGAATACTGGCTCAAGAACCTATGTCAAGATGAGCTGAATTTT 1521 GGTAAATTATTTTAGGAATTATGACAAGCTAATTGAATTAGGCTTGTGACAATTAGAGTAATTTACATGACAGGTAAAAC 1601 TCCTATTAAAAATGTTTAGATGTTTGCTTCTGTAGATGTCACTTTAGTAAAATACCAATTTAGTTTTACTTGTGGCTTAT 1681 CTAGTTAGAACTTAGCAGACTTTACTGGGACAAGTTTACTGCTCTTGTAGGAGCTCCTCTCACAAGTAGTTGTAATGCTG 1761 TAGCATGATACTCAGGATCAGTAGCTTGAGATGCTACTATTTTTCTCTTCATCTTTGACTTGCAGAGAGCCTCCCGTTTT 1841 TGGATCCAGGCATCTTTTCTGAATCCTGGTTCCATCAGTATACCTGCTCTCCTATGACCCCAAATCATAGTCAATGGTGC 1921 CTCAAACATAGCACCTTAAGTTAAAGGCTGCCTAGTGCTCTGAGGAAAGCTTGCTGATTATCTTCCTGATCTACTCACCC 2001 CAAAAGGCAGAAAAGCAACACAGTCACTGCTGTGGTCATTTGTAATGTAAAGATCAGTTATATATATATATTTGTAATGA 2081 GAGCAAGTATATACTCATTATAGAATCAATTTAAGAAGTTTAAAATAACCCAGAGTAGAATTTCTATATCTAGTCTTGGT 2161 TTTTTTCATGAATATTTGCAAGTAATTACCATTAAATTCACACATGAAAGATTAATCTGAAAGATCAGAGACCATGTTAT 2241 TCCTGACCACGATAGAACTGCTCCTGTGGTTTGGGACAAGTAATAAAACAACTGCTTGAGTTTTGTTTGTAAAATACATA 2321 ATTAATATTTGACCTACCTCAAAATGTATTGAGGATCTGTGAAATGCTAAGTGCCCAAAATAAAATATTGCTGATTGTCT 2401 TTTTATTAAAAGTAAATTTCCTCATTAAGCCAACCTGCCTTCTGTAAGTCACAGTGCTTAAATCTCAGGATTTTTCATTA 2481 GGAGAGACCTGTCGTTAAGGATTTGTAGGTATAATTGCTTAGCCTCCATTATTGGTGCTTGGGATAGAGAGGTTTTAGAT 2561 TTTTGTTTTTTTTTTGTTCTGCCTCAAAGCTCAGTTTATTGAAGACATTTGTAAGCTATTGGATCATCACTTGAATCAAG 2641 ATTTTGACTAGTGAGCTTAATTGTCCATTTCTTACAATTTCAAAGTTACAGTCTCAGAAATGGTTAATTTTAATAACTGT 2721 CCTATCATAAATTAATGTTGGAATAAATTGAAGTTGTTGATAAATACTTCATGAAAACTAAAGTCTGAAATAAATTACTT 2801 GTTTTATGTCCAATAGCTACTACATTTGATAGAACAGTTTTGAGGAACATTTCATTCTTGAACGCAGCATCTGACATGGT 2881 TCTCAGCAAGTTGGAATAGTAAGGATTATTGGCTTGTTTCGATGAGTGGAAGCGGCATGTTTGTAGCATACAAGTTATTC 2961 AATAATCTTGTGCTGATGACCTAAAAATATGTCTTAACTATTCATCAAGGAAAGCCTGGTGAAGCCTTTACTTGTTACTA 3041 CTTCAACAGTTGGAATTAGTTGCTCTTTTTACTTGATGAAACAAAACTATACCTCTGAATATTTATGGATACTTTTTACT 3121 AAATCAGGCTTGTGTTCTTAATCCAAATTAGTAAAGTTTTATGGAAGCTGAAATGTAATACAGTAGTCTCCCCTTATCTG 3201 TAAGAGATACATTCCAAGACCCCTAGTGGATGCCTGAAACCTCAGATAGTACTGAACCCTTTATCAACTATGTTTTTTCA 3281 GTCTGACAACCAAGGCGGCTACTAAGTGACTAAGGGGCAGGTAGTATACAGTGTGGATAAGCAGGACAAAGGGGTGATTC 3361 ACATCCCAGGCAGGACAGAGCAGGAGATCATGAGATTTCATCACTCAGGATGGCTTGTGATTTATTTTATTTTATTCTTT 3441 TTTTTTTTTGAGATGGAGTCTCACTCTTGCCCAGGCTGGAGTGCAGTGGTGCGATCTTGGCTCACTGCAACCTCTGCCTC 3521 CTGGGTTCAAGCAGTTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCGTCCGCCACCATGCCCAGCCAATTTT 3601 TGTACTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAGGTGATCCACTCGCCT 3681 CGGCCTCCCAAAGTGCTGGGATTATAGGCATGCGCCACCATGCCCGGCCGGCTTATGATTTAAAACATGAATTGTTTATT 3761 TCTGGAATTTTCCACATAATATTTTTGGACCAAGGTTGCCTCAGGTAACAAACTACAGAAAGTGAAATTGCAGATAAAGG 3841 GGATTACTGCTCCTCTGCTCTAAAATTGGTGTTTGGGTGATCAGAAGCAGGTAGCCAATGGGAAGAGCACTTCTGAGTGA 3921 TAACTAAAGCAGTTTGGTGGCCTTTTCACATTCTCCAATGTTCAAACATATTTTCCACTTTCCATTTTCTCTTTCACCTC 4001 ATTTTGCCTCTCTATCCCCCATCCCTGCTTATTTCTTAAGCCCATTGATGGCACTCATTAAATTGTATTTAGGGCTAATG 4081 AGTCATTGTTCCTTAATATCGTTTTCAATATGCCACAATTTAGGACACATTTAAAATTTTCTAAAACAATATCCTAATCA 4161 ATATTGACTAATTTGAGCCACATTCCCAACTCTAACTCAGCACACACTGCCAGTCTTCCCCAATATCTGTCTCCTCTCAA 4241 TTCCCCACCACACCTTATAAAATTGTAATCAAAGATATCTCACTCTGTCATTGTTAATCTAAGAATAAAAACACTGACTT 4321 TAATACGGTTTTACTAAGTTTCAACCTTCTAATTAGGTAGGCCTCTAGGTATTCTGCAGATCACTGCTGGTCTTGATAGC 4401 CATTAATATATGTTTGTATTATGTTATTTTTCAACTAAATCGCAGTTGGAAAAAAACATATTTAATATTATGCCCTTGGA 4481 TCTGTTACTGCATCACTAGCACTTGTGATGCAATAGAACACTTCGCCTGTACTGAAAGGGCCAAGAGTAAATGCCTTGTT 4561 TTGTTTTTTTGTTTTGTTTTGTTTTGCTTTTTGTTAAAACATGTCTATAGAGTTGGCAGTTAATGCTGAATTTGTCAAAT 4641 ACCCCTTCCAAAATTATACTTGTATTTAAAAAATAAATGGATCTACCTAATTTCTATTGATTTAATTTGCAGTTTTGTCT 4721 TATTAAAGTGGTATGTTTTTCAGTGTATTTTTTCTGAAGTTGATCTCTTTACATTTCAGCTATTACTGTATGCAGGAAGA 4801 AACTGACTTGTAATCTTTGATTTTTTTTTTTTTTTTGCATTTGTAAAGGCTTTGTACTTAAGGTAGGATTAAATGTTTGC 4881 AGATTGTGAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 10776.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 10776.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000566423.1 | 3UTR | AAACUUUUUACUUCCACACUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000566423.1 | 3UTR | AAACUUUUUACUUCCACACUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000566423.1 | 3UTR | AAACUUUUUACUUCCACACUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000566423.1 | 3UTR | AAACUUUUUACUUCCACACUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
70 hsa-miR-3911 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT207399 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 6 | ||||||
MIRT284537 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT291946 | TPM4 | tropomyosin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT293609 | PVR | poliovirus receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT357688 | PAIP2 | poly(A) binding protein interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451607 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452110 | IFITM1 | interferon induced transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457804 | KLHL25 | kelch like family member 25 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462730 | EFNB1 | ephrin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463219 | ZNF131 | zinc finger protein 131 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464141 | VPS28 | VPS28, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT467582 | SLC7A5 | solute carrier family 7 member 5 | ![]() |
![]() |
2 | 6 | ||||||
MIRT470824 | PLXND1 | plexin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474230 | LCLAT1 | lysocardiolipin acyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478989 | COLGALT1 | collagen beta(1-O)galactosyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479462 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483558 | SYT2 | synaptotagmin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484483 | SLC9A1 | solute carrier family 9 member A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485224 | PRICKLE1 | prickle planar cell polarity protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490356 | DPYSL5 | dihydropyrimidinase like 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT493177 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT509802 | CHAF1B | chromatin assembly factor 1 subunit B | ![]() |
![]() |
2 | 4 | ||||||
MIRT511815 | HDGF | heparin binding growth factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT512254 | ARPP19 | cAMP regulated phosphoprotein 19 | ![]() |
![]() |
2 | 6 | ||||||
MIRT513025 | GPT2 | glutamic--pyruvic transaminase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519640 | ZNF772 | zinc finger protein 772 | ![]() |
![]() |
2 | 4 | ||||||
MIRT531178 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | ![]() |
![]() |
2 | 2 | ||||||
MIRT537870 | EDA2R | ectodysplasin A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT551914 | IGLON5 | IgLON family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558359 | DMTF1 | cyclin D binding myb like transcription factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559771 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | ![]() |
![]() |
2 | 4 | ||||||
MIRT559813 | ZNF83 | zinc finger protein 83 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561999 | LPP | LIM domain containing preferred translocation partner in lipoma | ![]() |
![]() |
2 | 2 | ||||||
MIRT565754 | SERTAD2 | SERTA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569423 | DCAF8 | DDB1 and CUL4 associated factor 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569845 | RGS5 | regulator of G protein signaling 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT606928 | CDK15 | cyclin dependent kinase 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607616 | TMEM130 | transmembrane protein 130 | ![]() |
![]() |
2 | 4 | ||||||
MIRT607629 | TRIOBP | TRIO and F-actin binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT607885 | SATB1 | SATB homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607942 | SSX2 | SSX family member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608017 | CARNS1 | carnosine synthase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608036 | UBLCP1 | ubiquitin like domain containing CTD phosphatase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608063 | SSX2B | SSX family member 2B | ![]() |
![]() |
2 | 4 | ||||||
MIRT608558 | SBK1 | SH3 domain binding kinase 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT608915 | NCDN | neurochondrin | ![]() |
![]() |
2 | 6 | ||||||
MIRT615876 | HIF1AN | hypoxia inducible factor 1 alpha subunit inhibitor | ![]() |
![]() |
2 | 4 | ||||||
MIRT618023 | ELFN1 | extracellular leucine rich repeat and fibronectin type III domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT620505 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT628101 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628700 | ZNF548 | zinc finger protein 548 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630658 | POU2F1 | POU class 2 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643508 | ZNF28 | zinc finger protein 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646379 | SLC22A6 | solute carrier family 22 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660041 | C15orf61 | chromosome 15 open reading frame 61 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687700 | KRR1 | KRR1, small subunit processome component homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT688858 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690443 | REPIN1 | replication initiator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690456 | ZNF33A | zinc finger protein 33A | ![]() |
![]() |
2 | 2 | ||||||
MIRT693796 | RHOG | ras homolog family member G | ![]() |
![]() |
2 | 2 | ||||||
MIRT694274 | ZNF529 | zinc finger protein 529 | ![]() |
![]() |
2 | 4 | ||||||
MIRT697697 | WAC | WW domain containing adaptor with coiled-coil | ![]() |
![]() |
2 | 2 | ||||||
MIRT700242 | RCC2 | regulator of chromosome condensation 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701836 | MRPL37 | mitochondrial ribosomal protein L37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT704255 | DHCR24 | 24-dehydrocholesterol reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT707203 | SDK2 | sidekick cell adhesion molecule 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710365 | CREB5 | cAMP responsive element binding protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711943 | WDFY1 | WD repeat and FYVE domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715496 | MAZ | MYC associated zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT719250 | MS4A1 | membrane spanning 4-domains A1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|